TUMOR REMISSION--TAXOL AND CLOSE ANALOGS VIA SYNTHESIS
肿瘤缓解——紫杉醇及其类似物的合成
基本信息
- 批准号:2405847
- 负责人:
- 金额:$ 7.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-01-15 至 1998-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: Taxol and its close structural relatives represent very
demanding targets for the implementation of de novo synthetic tactics. This
is a consequence of their high structural complexity and abundant
stereochemical detail. The routes developed to the present time were
designed primarily to demonstrate that taxol can be prepared in the
laboratory. None can be categorized as particularly efficient. Seemingly
the best way to improve overall synthetic efficiency is to reduce the number
of requisite steps and utilize highly efficient processes. The primary goal
of the present effort is to develop an abbreviated route to taxol by
addressing at least two central rearrangements, which have been demonstrated
highly functionalized settings to be capable of meeting the stated needs.
The approach is therefore one designed around the tactic of elaborating the
entire taxane ring system early by submitting simple 1,2-adducts of
D-camphor derivatives to sequential charge-accelerated oxy-Cope and
alpha-ketol rearrangements alongside new, specifically tailored reactions.
A synthesis of taxusin, which takes advantage of many of these concepts, has
been completed.
The protocol will rely heavily on the use of D-camphor, an inexpensive,
enantiomerically pure commodity isolated from the camphor tree, in order to
produce the targeted compounds in their proper absolute configuration.
Emphasis is to be placed on brevity; consequently, very reasonable
regiocontrol and a minimum of protection/deprotection maneuvers are to be
deployed. Flexibility will also be paramount, such that minor changes in
methodology will allow for adaptation of the intermediates to arrival at
several targeted end-products.
The first priority is to arrive at taxol. Once the route to taxol is made
evident and is progressing well, real time will be devoted to structural
modifications. The ancillary objectives will include the preparation of
1-deoxytaxol and its alpha-oxetanyl isomer where the D ring is fused to the
alpha-surface of the framework.
描述:紫杉醇及其结构上的近亲具有很好的代表性
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LEO A PAQUETTE其他文献
LEO A PAQUETTE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LEO A PAQUETTE', 18)}}的其他基金
TUMOR REMISSION--TAXOL AND CLOSE ANALOGS VIA SYNTHESIS
肿瘤缓解——紫杉醇及其类似物的合成
- 批准号:
6416187 - 财政年份:2000
- 资助金额:
$ 7.16万 - 项目类别:
TUMOR REMISSION--TAXOL AND CLOSE ANALOGS VIA SYNTHESIS
肿瘤缓解——紫杉醇及其类似物的合成
- 批准号:
6559330 - 财政年份:2000
- 资助金额:
$ 7.16万 - 项目类别:
TUMOR REMISSION--TAXOL AND CLOSE ANALOGS VIA SYNTHESIS
肿瘤缓解——紫杉醇及其类似物的合成
- 批准号:
6027868 - 财政年份:2000
- 资助金额:
$ 7.16万 - 项目类别:
TUMOR REMISSION--TAXOL AND CLOSE ANALOGS VIA SYNTHESIS
肿瘤缓解——紫杉醇及其类似物的合成
- 批准号:
6350406 - 财政年份:2000
- 资助金额:
$ 7.16万 - 项目类别:
TUMOR REMISSION--TAXOL AND CLOSE ANALOGS VIA SYNTHESIS
肿瘤缓解——紫杉醇及其类似物的合成
- 批准号:
6628425 - 财政年份:2000
- 资助金额:
$ 7.16万 - 项目类别:
TUMOR REMISSION--TAXOL AND CLOSE ANALOGS VIA SYNTHESIS
肿瘤缓解——紫杉醇及其类似物的合成
- 批准号:
6551975 - 财政年份:2000
- 资助金额:
$ 7.16万 - 项目类别:
TUMOR REMISSION--TAXOL AND CLOSE ANALOGS VIA SYNTHESIS
肿瘤缓解——紫杉醇及其类似物的合成
- 批准号:
6497941 - 财政年份:2000
- 资助金额:
$ 7.16万 - 项目类别:
TUMOR REMISSION--TAXOL AND CLOSE ANALOGS VIA SYNTHESIS
肿瘤缓解——紫杉醇及其类似物的合成
- 批准号:
2105131 - 财政年份:1995
- 资助金额:
$ 7.16万 - 项目类别:
TUMOR REMISSION--TAXOL AND CLOSE ANALOGS VIA SYNTHESIS
肿瘤缓解——紫杉醇及其类似物的合成
- 批准号:
2008491 - 财政年份:1995
- 资助金额:
$ 7.16万 - 项目类别:
TUMOR REMISSION--TAXOL AND CLOSE ANALOGS VIA SYNTHESIS
肿瘤缓解——紫杉醇及其类似物的合成
- 批准号:
2105130 - 财政年份:1995
- 资助金额:
$ 7.16万 - 项目类别:
相似海外基金
The analysis of proteinuria caused by antineoplastics and the preventative effects with antihypertensive medications using the Japanese medical database
利用日本医学数据库分析抗肿瘤药物引起的蛋白尿及抗高血压药物的预防效果
- 批准号:
21K17258 - 财政年份:2021
- 资助金额:
$ 7.16万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Expediting Drug Development by Profiling Novel Antineoplastics by Mass Spectrometry-based Biomarker Profiling
通过基于质谱的生物标志物分析来分析新型抗肿瘤药物,加速药物开发
- 批准号:
499958-2016 - 财政年份:2016
- 资助金额:
$ 7.16万 - 项目类别:
Engage Grants Program
Combinatorial Peptidomimetics as Antineoplastics
作为抗肿瘤药的组合肽模拟物
- 批准号:
6623455 - 财政年份:2002
- 资助金额:
$ 7.16万 - 项目类别:
Combinatorial Peptidomimetics as Antineoplastics
作为抗肿瘤药的组合肽模拟物
- 批准号:
6465958 - 财政年份:2002
- 资助金额:
$ 7.16万 - 项目类别:
Novel Nanoparticle Delivery System for Antineoplastics
新型抗肿瘤纳米颗粒输送系统
- 批准号:
6483914 - 财政年份:2002
- 资助金额:
$ 7.16万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6124630 - 财政年份:1998
- 资助金额:
$ 7.16万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6329037 - 财政年份:1998
- 资助金额:
$ 7.16万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
2747737 - 财政年份:1998
- 资助金额:
$ 7.16万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459680 - 财政年份:1990
- 资助金额:
$ 7.16万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459678 - 财政年份:1990
- 资助金额:
$ 7.16万 - 项目类别: